These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Study on the modulation of estrogen receptor isoforms alpha in endometrial carcinoma cells using antisense oligodeoxyribonucleotides]. Zhang Y, Liao QP, Yu L, Chen CL, Zhao J. Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr 18; 37(2):155-8. PubMed ID: 15841144 [Abstract] [Full Text] [Related]
3. [Effects of estrogen, progestin and mifepristone on endometrial carcinoma cell lines]. Lu Y, Yu L, Chen CL, Liao QP. Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun 18; 37(3):284-6. PubMed ID: 15968321 [Abstract] [Full Text] [Related]
4. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action. Kumar NS, Richer J, Owen G, Litman E, Horwitz KB, Leslie KK. Cancer Res; 1998 May 01; 58(9):1860-5. PubMed ID: 9581825 [Abstract] [Full Text] [Related]
5. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines. Smid-Koopman E, Blok LJ, Kühne LC, Burger CW, Helmerhorst TJ, Brinkmann AO, Huikeshoven FJ. J Soc Gynecol Investig; 2003 Jan 01; 10(1):49-57. PubMed ID: 12517594 [Abstract] [Full Text] [Related]
6. Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin. Lessey BA, Ilesanmi AO, Castelbaum AJ, Yuan L, Somkuti SG, Chwalisz K, Satyaswaroop PG. J Steroid Biochem Mol Biol; 1996 Sep 01; 59(1):31-9. PubMed ID: 9009235 [Abstract] [Full Text] [Related]
7. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation. Dai D, Kumar NS, Wolf DM, Leslie KK. Am J Obstet Gynecol; 2001 Apr 01; 184(5):790-7. PubMed ID: 11303185 [Abstract] [Full Text] [Related]
10. Function of estrogen receptor isoforms alpha and beta in endometrial carcinoma cells. Zhang Y, Liao Q, Chen C, Yu L, Zhao J. Int J Gynecol Cancer; 2006 Apr 01; 16(4):1656-60. PubMed ID: 16884380 [Abstract] [Full Text] [Related]
11. Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor. DeMarzo AM, Oñate SA, Nordeen SK, Edwards DP. Biochemistry; 1992 Nov 03; 31(43):10491-501. PubMed ID: 1420166 [Abstract] [Full Text] [Related]
12. Agonist and antagonist-induced qualitative and quantitative alterations of progesterone receptor from breast cancer cells. Hurd C, Nag K, Khattree N, Alban P, Dinda S, Moudgil VK. Mol Cell Biochem; 1999 Sep 03; 199(1-2):49-56. PubMed ID: 10544951 [Abstract] [Full Text] [Related]
15. Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines. Qu W, Zhao Y, Wang X, Qi Y, Zhou C, Hua Y, Hou J, Jiang SW. Clin Chim Acta; 2019 Feb 03; 489():225-232. PubMed ID: 30107158 [Abstract] [Full Text] [Related]
16. Specific inhibition of estrogen receptor alpha function by antisense oligodeoxyribonucleotides. Taylor AH, Pringle JH, Bell SC, Al-Azzawi F. Antisense Nucleic Acid Drug Dev; 2001 Aug 03; 11(4):219-31. PubMed ID: 11572599 [Abstract] [Full Text] [Related]
17. The role of progesterone and its receptor on cyclin G1 expression in endometrial carcinoma cells. Liu F, Gao X, Yu H, Yuan D, Zhang J, He Y, Yue L. Reprod Sci; 2012 Nov 03; 19(11):1205-10. PubMed ID: 22649121 [Abstract] [Full Text] [Related]